Application no. and date | 11705713.3 (espacenet) (Federated) (European Patent Register), 20110112 | Patent/reg. no. and date | DK/EP 2523688, 20171011 | Publication date | 20121121 | Priority no. and date | US 295387 P, 20100115, US 422059 P, 20101210 | EP pub. no. and date |
EP 2523688 20121121 | Effective date | | Applicant/owner | Kirin-Amgen, Inc., One Amgen Center Drive
Thousand Oaks CA 91320-1799, US | Applicant ref. no. | P63023DK01 | Inventor | MARTIN, David Andrew, 6515 20th Avenue NE
Seattle Washington 98115, US, LIU, Dingjiang, 766 Bellagio Court
Oak Park California 91377, US, HUANG, Holly Zhuohong, 1792 Amarelle Street
Thousand Oaks California 91320, US, RUSSELL, Christopher Boyd, 3570 Crystal Springs Dr. NE
Bainbridge Island Washington 98110, US, SALINGER, David H., 6234 29th Avenue NE
Seattle Washington 98115, US, BAUMGARTNER, Scott Walter, 3020 Hollycrest Avenue
Thousand Oaks California 91362, US, ENDRES, Christopher J., 3258 NW Market Street
Seattle Washington 98107, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 17/06 (2006.01) , C07K 16/28 (2006.01) | Title | ANTISTOFFORMULERING OG TERAPEUTISKE REGIMENER | Int. application no. | US2011020985 | Int. publication no. | WO2011088120 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|